Monitor for any post-conference announcements regarding distribution deals or clinical data presentations in Europe; however, no immediate catalyst is expected. The event supports long-term market expansion but does not indicate near-term revenue inflection.
Price Chart
Executive Summary
Catheter Precision, Inc. (VTAK) announced plans to attend the EHRA 2026 conference in Paris, where it will promote its LockeT device following CE Mark approval. The company will engage with key opinion leaders and expand awareness among European physicians and distributors. No financial results, product sales data, or new developments beyond prior regulatory approvals were disclosed.
Key Facts
- Catheter Precision will attend the EHRA 2026 conference in Paris from April 12–14, 2026.
- The company plans to promote its LockeT suture retention device, which has received CE Mark approval.
- LockeT is indicated for wound closure after percutaneous venous punctures and is FDA-registered and CE Mark-approved.
- The VIVO 3D imaging system for ventricular arrhythmias also has FDA clearance and CE Mark.
- No financial figures, sales data, or material updates on operations or guidance were provided.
Financial Impact
No immediate financial impact disclosed
Risk Factors
- Limited market visibility due to lack of disclosed commercial performance metrics
- No assurance of successful commercial uptake in Europe despite CE Mark
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3270025 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 9, 2026 17d ago | 8-K | $1.00 $0.8200 | ▲ +18.00% | ▲ +16.51% | $0.6500 (+35.00%) |
Oct 5, 2026 22d ago | Press Release | $1.62 $1.00 | ▼ −38.27% | ▼ −38.69% | $0.6500 (−59.88%) |
Oct 2, 2026 24d ago | 8-K | $1.62 $1.00 | ▼ −38.27% | ▼ −38.69% | $0.6500 (−59.88%) |
Oct 2, 2026 24d ago | Press Release | $1.62 $1.00 | ▼ −38.27% | ▼ −38.69% | $0.6500 (−59.88%) |
Sep 28, 2026 29d ago | Press Release | $0.1467 | awaiting T+5 | — | $0.6500 (+343.08%) |
Sep 25, 2026 4w ago | 8-K | $0.1467 | awaiting T+5 | — | $0.6500 (+343.08%) |
Aug 27, 2026 8w ago | Press Release | $0.2027 $0.1966 | ▼ −3.01% | ▼ −3.28% | $0.6500 (+220.67%) |
Aug 11, 2026 11w ago | Press Release | $0.2900 $0.2229 | ▼ −23.14% | ▼ −22.73% | $0.6500 (+124.14%) |
Aug 4, 2026 12w ago | Press Release | $0.2760 $0.2930 | ▲ +6.16% | ▲ +6.26% | $0.6500 (+135.51%) |
Jul 13, 2026 15w ago | EFFECT | $0.6504 $0.5020 | ▲ +22.82% | ▲ +21.87% | $0.6500 (+0.06%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers